Here are five highlights:
1. The company’s $0.19 earnings per share for the third quarter beat the Thomson Reuters’ consensus estimate by $0.11.
2. In the same time period in 2015, the company had a $0.25 earnings per share.
3. During Q3 2016, K2M earned $59.30 million, over the consensus estimate of $58.21 million.
4. K2M saw a negative net margin of 16.45 percent and a negative return on equity of 12.97 percent in Q3 2016.
5. The company’s revenue for Q3 2016 saw a 7.8 percent increase on a year-over-year basis.
More articles on devices:
Medovex reports DenerveX System living tissue population test results: 6 key points
Wright Medical Group settles metal-on-metal hip litigation for $240M: 5 things to know
US spine implants market to grow at CAGR of 5.29% through 2020: 4 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
